Hillsborough, NJ, United States of America

Shiwei Tao

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 8.4

ph-index = 5

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

16 patents (USPTO):

Title: Inventor Shiwei Tao: An Innovator in Pharmaceutical Chemistry

Introduction

Shiwei Tao, an accomplished inventor located in Hillsborough, NJ, has made significant contributions to the field of pharmaceutical chemistry. With a total of 13 patents to his name, he has focused primarily on developing compounds that have the potential to be game-changers in the treatment of various diseases. His innovative work in the domain of LPA receptor inhibitors illustrates his commitment to advancing medical science.

Latest Patents

Among his latest patents, Shiwei Tao has developed compounds known as "Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists." These compounds, represented by Formula (I), include various stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates. The invention is particularly noteworthy because it highlights the selective inhibition of LPA receptors, which could lead to breakthroughs in therapeutic applications.

Career Highlights

Shiwei Tao has built an impressive career through his associations with renowned companies in the pharmaceutical industry. Notable firms that have benefited from his expertise include Bristol-Myers Squibb Company and Syngene International Limited. His extensive research and contributions to these companies have bolstered his reputation as a leading innovator in his field.

Collaborations

Throughout his career, Shiwei has collaborated with accomplished professionals in the industry, including his coworkers Yan Shi and Hao Zhang. These collaborations have likely fostered a rich exchange of ideas and advanced the development of novel pharmaceutical compounds.

Conclusion

In summary, Shiwei Tao stands out as a prominent inventor whose work in the field of pharmaceutical chemistry has led to a series of innovative patents. His focus on developing LPA antagonists reflects his dedication to addressing significant medical challenges. With a promising career ahead, Shiwei's contributions are sure to influence future advancements in healthcare and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…